HOME >> MEDICINE >> NEWS
Wake Forest establishes Maya Angelou Research Center on minority health

Campus and community partnerships both with Winston-Salem State University, a historically black university, and with the local community to create a nationally recognized model for addressing racial and ethnic health disparities.

Nationally recognized programs in underrepresented minority health education.

Nationally recognized research on underrepresented minority health related areas and in the development of mechanisms for the translation of new research findings into efficient, cost-effective preventive health care for underrepresented minority populations.

The school's leadership in the development and career advancement of underrepresented minority researchers, educators, clinicians and leaders.

"In establishing the Maya Angelou Research Center on Minority Health, we will create a model that can be replicated to serve the health needs of other communities across the nation," said Dean.

The School of Medicine already has a broad range of leading research and clinical programs in the six major focus areas in minority health targeted by the United States Department of Health and Human Services: infant mortality; cancer screening and management; cardiovascular diseases; diabetes; HIV infection; and child and adult immunizations.

The programs range from basic and clinical studies on contributing factors for the development of hypertension and other vascular diseases in African Americans to a federally funded study designed to address cultural barriers to breast cancer screening. In addition, the Downtown Health Plaza of Baptist Hospital serves most of the uninsured children in Forsyth County and approximately half of the children with Medicaid coverage.

The racially diverse population of Forsyth County and the burden of disease and prevalence of risk factors in the community create an appropriate setting for the Maya Angelou Research Center on Minority Health, as well as an urgent need for applying multidisciplinary
'"/>

Contact: Jim Steele, Mark Wright or Bob Conn
jsteele@wfubmc.edu
336-716-4587
Wake Forest University Baptist Medical Center
11-Feb-2002


Page: 1 2 3 4

Related medicine news :

1. Experimental drug improves sleep in older patients, Wake Forest Baptist study shows
2. Researchers at Wake Forest University Baptist use Botox to treat CP
3. Forest mapping from space supports Kyoto Protocol
4. Latino farm workers cant afford sufficient food Wake Forest study shows
5. Wake Forest pediatric heart surgeon to repair heart defect on live Webcast
6. Wake Forest researchers find brain region exquisitely sensitive to alcohol
7. Multimillion-dollar pain research center funded at Wake Forest
8. UNC, Wake Forest scholars work to reduce crimes against Hispanics in North Carolina
9. Wake Forest University Baptist Medical Center participates In largest-ever prostate cancer prevention trial
10. Smokers more likely to experience impotence, Wake Forest study shows
11. Wake Forest first in world to perform new brain tumor treatment

Post Your Comments:
(Date:6/18/2013)... June 18, 2013 David Connett, DO, ... Family Medicine for the College of Osteopathic Medicine of ... has been elected president of the Osteopathic Medical ... Brown Jr. appointed Connett, a 1984 alumnus of COMP, ... recently elected Connett to the position during a conference ...
(Date:6/18/2013)... N.Y., June 18, 2013 -- Lauren Sciences, a ... V-Smart nanovesicle platform technology, announced today that it ... Drug Delivery with its V-Smart Platform, and selected ... by MCD Group. , The report, ... Start-ups and Emerging Companies ," features companies MCD ...
(Date:6/18/2013)... enrolled their first patients in the ROADSTER Study, a ... to help clear blockages in carotid arteries and prevent ... in the United States are diagnosed with blockages, or ... blockages can slow or even stop blood flow to ... as a "brain attack." , Current treatment options ...
(Date:6/18/2013)... scrambling to gather data for the FDA to support ... injury in the United States. The University of Rochester ... the Journal of Neurotrauma that it might ... of one., Jeffrey J. Bazarian, M.D., M.P.H., an associate ... first to show that measuring a combination of two ...
(Date:6/18/2013)... system using a person,s DNA was announced as ... London Startup Competition, Europe,s largest technology conference. ... on University of Bristol research by its founders, ... Professor of Bioinformatics in the University,s Department of ... to be one of 16 finalists in the ...
Breaking Medicine News(10 mins):Health News:UH Case Medical Center among first to enroll patients for global carotid artery trial 2
(Date:6/18/2013)... 18, 2013  Cataracts are the leading cause of ... of Ophthalmology, aging is the leading cause of eye ... natural lens. 22 million Americans age 40 and older ... to age, that number will increase over 30 million. ... iPads, smart-phones and computers, the demographic of ages 40 ...
(Date:6/18/2013)... , June 18, 2013  Decision Resources, ... firms for pharmaceutical and healthcare issues, announces that ... of the Middle East ... Tracker analyzes the challenges and opportunities to gaining ... international regions comprising 24 countries. The countries covered ...
(Date:6/18/2013)... NEW YORK , June 18, 2013 ... Gilead Sciences, Inc. (NASDAQ: GILD ), Health Management ... (NASDAQ: IDXX ), ISIS Pharmaceuticals Inc. (NASDAQ: ... readers may access these reports free of charge - including ... the links below. Gilead Sciences, Inc. Research Report ...
Breaking Medicine Technology:New Vision Hope For Millions Undergoing Cataract Surgery 2New Vision Hope For Millions Undergoing Cataract Surgery 3Decision Resources' Market Access Tracker Now Covers the Middle East and Africa 2Decision Resources' Market Access Tracker Now Covers the Middle East and Africa 3Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics 2Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics 3Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics 4Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics 5Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics 6
Cached News: